Want to join the conversation?
$PFE and $BMY said they would collaborate with $PTLA to develop and commercialize andexanet alfa, an investigational drug used for the reversal of the anticoagulant activity of Factor Xa inhibitors in Japan. The drug is helpful for patients who experience excessive bleeding, while on inhibitors.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.